Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register

INTRODUCTION: Anti-TNF therapies represent a breakthrough in the treatment of severe psoriatic arthritis. However, little is known about long-term drug persistence with these treatments in patients with psoriatic arthritis in routine clinical practice. The aim of this study was to assess persistence...

Descripción completa

Detalles Bibliográficos
Autores principales: Saad, Amr A, Ashcroft, Darren M, Watson, Kath D, Hyrich, Kimme L, Noyce, Peter R, Symmons, Deborah PM
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688203/
https://www.ncbi.nlm.nih.gov/pubmed/19356232
http://dx.doi.org/10.1186/ar2670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688203/
https://www.ncbi.nlm.nih.gov/pubmed/19356232
http://dx.doi.org/10.1186/ar2670

Ejemplares similares